| Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ... Nature genetics 45 (1), 12-17, 2013 | 551 | 2013 |
| Egr-2 and Egr-3 are negative regulators of T cell activation M Safford, S Collins, MA Lutz, A Allen, CT Huang, J Kowalski, A Blackford, ... Nature immunology 6 (5), 472-480, 2005 | 508 | 2005 |
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ... Gastroenterology 149 (6), 1501-1510, 2015 | 484 | 2015 |
| RNAi-mediated silencing of nuclear factor erythroid-2–related factor 2 gene expression in non–small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy A Singh, S Boldin-Adamsky, RK Thimmulappa, SK Rath, H Ashush, ... Cancer research 68 (19), 7975-7984, 2008 | 452 | 2008 |
| SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer A Blackford, OK Serrano, CL Wolfgang, G Parmigiani, S Jones, X Zhang, ... Clinical cancer research 15 (14), 4674-4679, 2009 | 448 | 2009 |
| Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance MI Canto, JA Almario, RD Schulick, CJ Yeo, A Klein, A Blackford, EJ Shin, ... Gastroenterology 155 (3), 740-751. e2, 2018 | 414 | 2018 |
| PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer SP Rowe, KJ Macura, E Mena, AL Blackford, R Nadal, ES Antonarakis, ... Molecular imaging and biology 18, 411-419, 2016 | 277 | 2016 |
| Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer EJ Childs, E Mocci, D Campa, PM Bracci, S Gallinger, M Goggins, D Li, ... Nature genetics 47 (8), 911-916, 2015 | 277 | 2015 |
| Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer AP Klein, BM Wolpin, HA Risch, RZ Stolzenberg-Solomon, E Mocci, ... Nature communications 9 (1), 556, 2018 | 259 | 2018 |
| Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma SY Cho, EJ Lipson, HJ Im, SP Rowe, EM Gonzalez, A Blackford, ... Journal of Nuclear Medicine 58 (9), 1421-1428, 2017 | 259 | 2017 |
| Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins Gut 64 (11), 1783-1789, 2015 | 254 | 2015 |
| 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 239 | 2015 |
| Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration‐resistant prostate cancer ES Antonarakis, EI Heath, DC Smith, D Rathkopf, AL Blackford, DC Danila, ... The oncologist 18 (2), 163-173, 2013 | 217 | 2013 |
| Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications JA Cintolo-Gonzalez, D Braun, AL Blackford, E Mazzola, A Acar, ... Breast cancer research and treatment 164, 263-284, 2017 | 209 | 2017 |
| Genetic mutations associated with cigarette smoking in pancreatic cancer A Blackford, G Parmigiani, TW Kensler, C Wolfgang, S Jones, X Zhang, ... Cancer research 69 (8), 3681-3688, 2009 | 205 | 2009 |
| Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ... Annals of surgical oncology 20, 3802-3808, 2013 | 196 | 2013 |
| Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy HA Knaus, S Berglund, H Hackl, AL Blackford, JF Zeidner, ... JCI insight 3 (21), e120974, 2018 | 192 | 2018 |
| Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis AL Blackford, MI Canto, AP Klein, RH Hruban, M Goggins JNCI: Journal of the National Cancer Institute 112 (11), 1162-1169, 2020 | 189 | 2020 |
| Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002 CF Snyder, KD Frick, ME Kantsiper, KS Peairs, RJ Herbert, AL Blackford, ... Journal of Clinical Oncology 27 (7), 1054-1061, 2009 | 187 | 2009 |
| The role of stereotactic body radiation therapy for pancreatic cancer: a single-institution experience S Moningi, AS Dholakia, SP Raman, A Blackford, JL Cameron, DT Le, ... Annals of surgical oncology 22, 2352-2358, 2015 | 176 | 2015 |
Ralph HrubanJohns Hopkins UniversityZweryfikowany adres z jhmi.edu
